Fingerprint
Dive into the research topics of 'Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically